Topic Statement:TCS is currently oversold, with upcoming quarterly results potentially driving a rebound from strong technical support levels. Key Points:
Day: July 6, 2025
Torrent Pharmaceuticals’ Strategic Acquisition of JB Chemicals: A Bold Move for Growth
In a landmark move that has sent ripples through the pharmaceutical sector, Torrent Pharmaceuticals has announced the acquisition of a controlling stake in JB ChemicalsView More